Marc Tessier-Lavigne released new details from his research and travel in an attempt to refute allegations in a new book that ...
Hospital prep a lobbying push, RFK Jr. faces more bad news on measles, and the cancer drug that helped Ben Sasse gets ...
Hear STAT reporters interview the year’s biggest newsmakers on the state of the industry. Y ou’re reading the web edition of ...
WASHINGTON — Sen. Bill Cassidy (R-La.) released a report on Thursday criticizing the Food and Drug Administration for not ...
The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first to ...
W WASHINGTON — Hospital leaders, stung by the passage of a law that will cut nearly $1 trillion in Medicaid funding over the ...
Today, we look at how a China biotech crackdown could benefit Europe, what a rival drug failure might mean for Alnylam, the ...
Biotech industry leaders must forge a new geographic path before heavy-handed legislation forces the issue,” write executives ...
The European Society of Cardiology Congress that kicks off Friday in Munich will be a consequential meeting for Alnylam ...
Hswen is an associate professor of epidemiology and biostatistics in the Artificial Intelligence Interdisciplinary Institute ...
A personalized cancer vaccine developed by Moderna and Merck may be a triumph of immunology and cancer biology. It might also be the triumph of an algorithm.
The FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results